[Wobenzym in the combined pathogenetic therapy of chronic urethrogenic prostatitis].

The paper addresses the issues of pathogenetic therapy of uretrogenous prostatitis, its key features being as follows: 1) association with pancreatic pathology; 2) the presence of noninfectious agent; 3) autoimmune character. The proposed treatment scheme includes wobenzyme, a polyenzymic drug preparation, capable of exerting positive effects in the treatment of the pathology in question, which fact bears relation to intimate mechanisms of evolution of chronic urethrogenous prostatitis.